Sanjivani Paranteral Profile
Key Indicators
- Authorised Capital ₹ 15.00 Cr
- Paid Up Capital ₹ 11.68 Cr
- Company Age 30 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.50 Cr
- Satisfied Charges ₹ 192.05 Cr
- Revenue Growth 16.82%
- Profit Growth -6.91%
- Ebitda -1.55%
- Net Worth 59.50%
- Total Assets 14.81%
About Sanjivani Paranteral
Sanjivani Paranteral Limited (SPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 05 October 1994 and has a history of 30 years and four months. Its registered office is in Mumbai, Maharashtra, India.
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 531569.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 15.00 Cr and a paid-up capital of Rs 11.68 Cr.
The company currently has active open charges totaling ₹5.50 Cr. The company has closed loans amounting to ₹192.05 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Sanjivani Paranteral Limited India are Pritesh Jain as CFO and Ravikumar Bogam as Company Secretary. Ashwani Khemka, Mrunmai Sarvankar, Monika Singhania, and Two other members serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
L24300MH1994PLC081752
- Company No.
081752
- Stock Symbol
BSE : 531569
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
05 Oct 1994
- Date of AGM
24 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Listed
- ROC Code
Roc Mumbai
Industry
What products or services does Sanjivani Paranteral Limited offer?
Sanjivani Paranteral Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Diabetes Medicine, Pain Relief Drugs & Pharmaceuticals, Arthritic Drugs, Antiviral Drugs.
Who are the key members and board of directors at Sanjivani Paranteral?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashwani Khemka  | Managing Director | 05-Oct-1994 | Current |
| Pritesh Jain | CFO | 26-Apr-2024 | Current |
| Ravikumar Bogam | Company Secretary | 31-Aug-2024 | Current |
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Srivardhan Khemka | Director | 24-Mar-2022 | Current |
| Mrunmai Sarvankar | Director | 31-Mar-2015 | Current |
| Monika Singhania | Director | 24-Mar-2022 | Current |
| Abhay Shah | Director | 26-Apr-2024 | Current |
Financial Performance of Sanjivani Paranteral.
Sanjivani Paranteral Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.82% increase. The company also saw a slight decrease in profitability, with a 6.91% decrease in profit. The company's net worth Soared by an impressive increase of 59.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sanjivani Paranteral?
In 2023, Sanjivani Paranteral had a promoter holding of 29.88% and a public holding of 70.12%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Lipi Data Systems LimitedMonika Singhania is a mutual person
Nhc Foods LimitedMonika Singhania is a mutual person
Spl Infusion Private LimitedAshwani Khemka and Mrunmai Sarvankar are mutual person
- Genesen Labs Limited
Ashwani Khemka is a mutual person
- Dolat Algotech Limited
Monika Singhania is a mutual person
Charges (Loans)
₹5.50 Cr
₹192.05 Cr
Charges Breakdown by Lending Institutions
- Others : 5.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Aug 2024 | Others | ₹5.00 M | Open |
| 31 Jul 2024 | Others | ₹5.00 Cr | Open |
| 26 Jun 2015 | Others | ₹4.00 Cr | Satisfied |
| 26 Dec 2014 | Others | ₹2.00 Cr | Satisfied |
| 14 Oct 2011 | Others | ₹1.00 Cr | Satisfied |
How Many Employees Work at Sanjivani Paranteral?
Sanjivani Paranteral has a workforce of 31 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sanjivani Paranteral, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanjivani Paranteral's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
